Statins may have immunomodulatory effects that benefit critically ill patients. Therefore we retrospectively examined the association between survival and the prescription of statins prior to admission to an intensive care unit (ICU), or high dependency unit (HDU), as a result of major elective surgery, or as an emergency with a presumed diagnosis of sepsis.
Introduction
Statins (3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors) are a widely prescribed class of drugs. While primarily intended to treat hypercholesterolaemia, statins may have other relevant therapeutic properties, independent of lipid-lowering effects. [1] [2] [3] For example, investigators have suggested that statins may have pleiotropic vascular endothelial effects that are immunomodulatory, anti-inflammatory, or antithrombotic. [4] [5] [6] [7] [8] As such, studies have sought to establish if there is an association between statinusage and outcomes following critical illness: such as infection, pneumonia, acute respiratory distress syndrome, and traumatic brain injury or stroke. [9] [10] [11] [12] [13] [14] [15] [16] Studies have also examined the putative link between the prior statin use and any reduction in the morbidity and mortality from major elective surgery. 17, 18 Despite widespread interest, there is still confusion regarding whether prescribing statins before admission to an intensive care unit (ICU), or high dependency unit (HDU), is associated with any subsequent increase or decrease in survival. For example, prior statin usage has been associated with increased mortality for patients who acquired infections while in ICU, but associated with decreased mortality in patients with multi-organ dysfunction. 19, 20 Moreover, most studies have only concentrated on short-term outcomes. As a result, it is also unclear whether statins should be continued or discontinued during critical illness. This study will further explore the association between prior use of statins and outcome in i) patients admitted to ICU or HDU as an emergency with presumed sepsis, and ii) patients electively admitted to ICU or HDU after major surgery.
Methods

Nottingham University Hospital (NUH) consists of the Queens Medical
Centre and Nottingham City Hospital, and is located in the Midlands of England. These two sites provide critical care support to a population of between one and four million, depending on the condition being treated.
Ethics approval was obtained from to perform a retrospective chart review of all adult patients admitted to NUH between January 1 st 2000 and December 31 st 2005 (inclusive). At that time there were 21 multidisciplinary ICU beds and 18 HDU beds.
Patients were identified using three databases which encompassed different critical care areas and were continuously maintained: the Intensive Care National Audit and Research Centre (ICNARC), and two locally maintained Microsoft Access™ databases. Two cohorts were identified: i) those with a presumed diagnosis of sepsis, and ii) those with elective admission following major surgery.
Any patient with unavailable or incomplete notes was excluded. Postoperative patients were excluded if their admission followed surgical or anaesthetic complications, or if surgery was otherwise non-elective (e.g., surgery for abscess drainage or perforated viscus). Only the first admission was counted for those with multiple admissions. If patients were deemed (from chart review) to be both septic and elective post-operative they were only included once, and in the first cohort to which they presented.
Chart review was performed (by MB, IJ, JC-S, KG, CL, and AA) to confirm demographics, reason for ICU/HDU admission, and any chronic 
Results
Approximately 6590 patients were admitted to the critical care units between January 1 st 2000 and December 31 st 2005. (Figure 1 ). Of these, a cohort of 414 patients was admitted for presumed sepsis, and 672 patients were admitted following major elective surgery. All study patients had their statin usage interrupted for at least some period of their admission to a critical care environment.
Patients who had been prescribed statins prior to admission were more likely to be older, and have marginally-higher APACHE II scores (Table 1 ). When comparing factors associated with inflammation or shock, the only statistically significant finding was that post-operative patients who had used statins were more likely to require inotropes (53% of patients in this group were prescribed adrenalin, noradrenaline or dopamine, compared with 38% of patients who had no prior statin usage, P=0.007).
Odds ratios were calculated for five-year survival, taking into account potential confounders ( (Figures 2 and 3 ).
An analysis of the crude mortality associated with different types of statin revealed a potential difference in survival (Table 4 ). Simvastatin was associated with worse hospital survival when compared with patients not prescribed statins (or prescribed atorvastatin). This association was only found in patients admitted with sepsis.
Discussion
We found little or no evidence of any association between statin usage and improved survival. This was true in the short-term (during ICU stay); the medium term (during hospital stay); the longer term (up to 5 years); and regardless of whether patients were admitted as an emergency (for presumed sepsis) or electively (after major surgery).
Following sepsis, previous studies have intimated that pre-existing statin therapy may reduce cytokine levels (specifically TNF-alpha and interleukin-6); may protect against progression from bacteraemia to severe sepsis; may mitigate the need for ICU admission; and may decrease overall mortality. [21] [22] [23] [24] [25] [26] Studies have also reported a reduction in attributable mortality from 20% to 3% (P = 0.010). 9 In contrast, our five-year study found no associated mortality-benefit between sepsis-survival and pre-prescription of a statin. Studies have also reported an association between prior statin use and lower morbidity and mortality after cardiac surgery, non-cardiac vascular surgery, and other non-cardiac surgery. [17] [18] [27] [28] Again, this was not duplicated in our study which found no survival advantage with a statin. Our goal was to investigate longer-term survival following major surgery in patients likely to have inflammation (as defined by the SIRS criteria), but not caused by sepsis.
Our study has many limitations that reduce the generalizability of our conclusions. These include: the retrospective nature, reliance upon chart records and presumptive diagnoses from a single centre; and the loss to follow up of twelve percent of patients. We did not confirm (or compare) patient's statin dose, or duration of therapy, or pre-admission compliance. Nor did we confirm any effect of statins in lowering serum-lipids or specific inflammatory markers. We also did not establish whether statins were continued (or started) after ICU-to-ward discharge, or after hospital-discharge.
Some patients were lost to follow up, most notably after major elective surgery. In 23 cases we know that the patients moved to another location. For the remainder all that is known is that after finishing attending follow-up clinics these patients did not require any further hospitalisation at our institution over the subsequent nine years. Some patients may have died in the community, without requiring hospital admission; or may have been admitted to other hospitals.
Also, although we strived to control for likely confounders, there could be others: this includes treating all sepsis as if it is a homogeneous disease.
Despite our aforementioned limitations, we also found no significant were not obviously septic but are known to be at risk, also did not demonstrate a benefit associated with statins. The counter argument could be that post-operative (non-septic) patients have too small an inflammatory response for statins to exert any effect.
In fact, post-operative patients appeared to be more likely die during their ICU stay if they had previously been prescribed statins (9% vs 3%, P=0.021; Table 2 ). Assuming this result to be a "true" one, the argument could be made that statin usage is harmful, or that it acts as a surrogate marker for high-risk patient groups (in which case any beneficial effect of statins could be masked by the risk of pre-existing illness). Equally, it is likely that a note of caution is required when interpreting this particular finding: the absolute numbers were small, and the increased mortality was not sustained to hospital discharge. Establishing the role of statins in ICU patients may be further complicated by ICU patient heterogeneity, especially when compared to cardiac patients (all of whom will presumably have vascular disease) or those with isolated lipid abnormalities (versus ICU patients who often have multisystem disease).
Pragmatically, one could argue that this study supports the conclusion that prior statin use does not seem to have a negative impact on long-term outcomes after admission to ICU. It has also been suggested that abrupt discontinuation of statins is associated with rapid loss of any inflammatory or endothelial benefit, and that there might be increased cardiac myonecrosis if statins are discontinued after major vascular surgery. [29] [30] [31] [32] [33] Accordingly, over time, a body of opinion has developed recommending that statins should be continued (where possible) upon ICU admission -a practice now adopted at NUH. [34] [35] We performed a sub-analysis, comparing the crude outcome data associated with different statins. Although we identified a potential increase in mortality associated with simvastatin in our cohort of septic patients, this was not replicated in post-operative patients. This should encourage further study, though we are mindful that statistical error can rise as sample size decreases.
Accordingly, the numbers of patients prescribed fluvastatin, pravastatin and rosuvastatin were too small to perform meaningful subanalysis. Nevertheless, there may be heterogeneity amongst statins. 36 pharmacokinetics and pharmacodynamics. [37] [38] [39] In short, much work remains to be done. Total number of admissions n=6590*
Eligible patients identified n=1101
Casenotes incomplete or unavailable for review n=15
Cohort 2 Patients admitted with a presumed diagnosis of sepsis n=414
Cohort 1 Patients admitted after major elective surgery n=672
Elective patients where outcome at 5 years could be confirmed n=576 Sepsis patients where outcome at 5 years could be confirmed n=382 Log rank test significance p=0.093 
